Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Etanercept in Kawasaki Disease

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborator:
Amgen
Information provided by (Responsible Party):
Michael Portman, Seattle Children's Hospital
ClinicalTrials.gov Identifier:
NCT00841789
First received: February 10, 2009
Last updated: October 13, 2016
Last verified: October 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: October 2016
  Primary Completion Date: July 2016 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):